Bengt Stefan Ståhl
Direktor/Vorstandsmitglied bei INTERVACC AB
Profil
Bengt Stefan Ståhl is the founder of Affibody AB, which was founded in 1999.
He held the position of Chief Scientific Officer from 1999 to 2002.
Currently, he holds the position of Chairman of the Board at KTH Holding AB, Independent Director at Intervacc AB since 2009, and Professor at the Royal Institute of Technology.
Aktive Positionen von Bengt Stefan Ståhl
Unternehmen | Position | Beginn |
---|---|---|
INTERVACC AB | Direktor/Vorstandsmitglied | 01.01.2009 |
KTH Holding AB
KTH Holding AB Investment ManagersFinance KTH Holding AB (KTH Holding) is a venture capital subsidiary of Royal Institute of Technology founded in 1994. The firm is headquartered in Stockholm, Sweden. | Vorsitzender | - |
Royal Institute of Technology | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Bengt Stefan Ståhl
Unternehmen | Position | Ende |
---|---|---|
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Gründer | 01.01.2002 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INTERVACC AB | Health Technology |
Private Unternehmen | 2 |
---|---|
KTH Holding AB
KTH Holding AB Investment ManagersFinance KTH Holding AB (KTH Holding) is a venture capital subsidiary of Royal Institute of Technology founded in 1994. The firm is headquartered in Stockholm, Sweden. | Finance |
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |